↓ Skip to main content

American Association for Cancer Research

Article Metrics

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors

Overview of attention for article published in Molecular Cancer Therapeutics, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
17 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
11 Mendeley